Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-α converting enzyme
- 19 November 2001
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (22), 2907-2910
- https://doi.org/10.1016/s0960-894x(01)00603-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Characterization of Matrix Metalloproteinase Inhibitors: Enzymatic AssaysCurrent Protocols in Pharmacology, 2001
- Enhancement of the surface expression of tumor necrosis factor α (TNFα) but not the p55 TNFα receptor in the THP-1 monocytic cell line by matrix metalloprotease inhibitorsBiochemical Pharmacology, 1999
- Aryl ketones as novel replacements for the C-terminal amide bond of succinyl hydroxamate MMP inhibitorsBioorganic & Medicinal Chemistry Letters, 1998
- The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitorsBioorganic & Medicinal Chemistry Letters, 1998
- Design and Synthesis of Cyclic Inhibitors of Matrix Metalloproteinases and TNF-α ProductionJournal of Medicinal Chemistry, 1998
- Crystal structure of the catalytic domain of human tumor necrosis factor-α-converting enzymeProceedings of the National Academy of Sciences of the United States of America, 1998
- A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cellsNature, 1997
- Tumor Necrosis Factor: Function, Release and ClearanceCritical Reviews in Immunology, 1996
- Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitorNature, 1994
- Processing of tumour necrosis factor-α precursor by metalloproteinasesNature, 1994